BioNTech SE (BNTX) Other financing activities (2019 - 2025)
BioNTech SE (BNTX) posted Other financing activities of -$13.4 million for Q3 2025, up 10.7% sequentially from -$15.1 million in Q2 2025, and down 54.96% YoY from -$29.8 million in Q3 2024.
BioNTech SE (BNTX) Other financing activities (2019 - 2025) Analysis & Trends
BioNTech SE has reported Other financing activities for 7 years, with the latest figure at -$13.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -13.44 Mn |
| Sep 30, 2025 | -13.44 Mn |
| Jun 30, 2025 | -15.06 Mn |
| Jun 30, 2025 | -15.06 Mn |
| Mar 31, 2025 | -14.52 Mn |
| Mar 31, 2025 | -14.52 Mn |
| Sep 30, 2024 | -8.68 Mn |
| Sep 30, 2024 | -8.68 Mn |
| Jun 30, 2024 | -24.66 Mn |
| Jun 30, 2024 | -24.66 Mn |
| Mar 31, 2024 | -8.47 Mn |
| Mar 31, 2024 | -8.47 Mn |
| Sep 30, 2023 | -338.55 Mn |
| Sep 30, 2023 | -338.55 Mn |
| Jun 30, 2023 | -177.93 Mn |
| Jun 30, 2023 | -177.93 Mn |
| Mar 31, 2023 | -312.66 Mn |
| Mar 31, 2023 | -312.66 Mn |
| Sep 30, 2022 | -658.81 Mn |
| Sep 30, 2022 | -658.81 Mn |